Skip to Content

TEVA 7335 (Topiramate (Sprinkle) 15 mg)

Pill with imprint TEVA 7335 is White, Capsule-shape and has been identified as Topiramate (Sprinkle) 15 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7335

Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335
Topiramate (sprinkle) 15 mg TEVA 7335

Topiramate (Sprinkle)

Imprint
TEVA 7335
Strength
15 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7335

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.